Clinical Trial Update: A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety and immunogenicity of an MVA-based monkeypox attenuated live vaccine; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• MVA Strain Monkeypox Attenuated Live Vaccine

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Monkeypox | Phase 1 | Status: RECRUITING